Here's some commentary on the recent Access Scientific news about the Access Scientific Powerwand and ASNB's Chronoflex C. It's from the independent "ivteam" nurse-run website. Bold is my emphasis
"The study found that ChronoFlex C with BioGUARD demonstrates thrombo-resistance where it matters most — on the surface of the blood vessel. No other catheter material has demonstrated this clinically important effect.
While other catheter manufacturers claim anti-thrombotic properties that reduce thrombus (clot) formation “on the surface of the catheter,” these anti-thrombotic claims cite in vivo or in vitro studies that show diminished thrombus formation solely on the surface of the catheter. This finding is often and mistakenly conflated with deep vein thrombosis (DVT) – a condition known to be associated with high-risk complications like bloodstream infection or blood clot embolization. There is no evidence that thrombo-resistance on the surface of the catheter has any effect on diminishing DVTs in actual patients.
Today’s announcement may serve to explain, at least in part, why Access Scientific’s POWERWAND™ catheters consistently demonstrate fewer DVTs and fewer total complications (including bloodstream infections) than other catheters used for similar purposes."
The "ivteam," from their twitter page "Vascular access and infusion therapy updates. IVTEAM are a global resource who deliver thousands of updates without financial or subscriber based restrictions."
News 
Market Data 
Discover 
